Matt Brazier's Investment Diary
Subscribe
Sign in
Home
Notes
UK Trading Portfolio
UK Investing Portfolio
Australia Portfolio
Archive
About
LON:OXB
Portfolio update 14 June 2025
Weekly news and trading intentions featuring LON:OXB, LON:TRST and LON:SAG
Jun 14
•
Matt Brazier
12
Share this post
Matt Brazier's Investment Diary
Portfolio update 14 June 2025
Copy link
Facebook
Email
Notes
More
5
MaxCyte (NASDAQ:MXCT, LON:MXCT): unsexy genes
An unloved stock and non-viral substitution competitor to Oxford BioMedica (LON:OXB) in the ex-vivo CGT market
May 31
•
Matt Brazier
6
Share this post
Matt Brazier's Investment Diary
MaxCyte (NASDAQ:MXCT, LON:MXCT): unsexy genes
Copy link
Facebook
Email
Notes
More
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts